As of Friday close, Surgery Partners Inc.’s (NASDAQ:SGRY) stock was up $0.52, moving up 1.62 percent to $32.65. The average number of shares traded per day over the past five days has been 571,860 shares. 1 time new highs have been achieved over the past 5 days, with a -$1.92 fall in that time frame. In the last twenty days, the average volume was 769,345, while in the previous 50 days, it was 803,254.
Since last month, SGRY stock retreated -19.98%. Shares of the company fell to $31.72 on 08/18/23, the lowest level in the past month. A 52-week high of $45.79 was reached on 06/30/23 after having rallying from a 52-week low of $20.46. Since the beginning of this year, SGRY’s stock price has risen by 17.19% or $4.79, and marked a new high 24 times. However, the stock has declined by -28.70% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
SGRY stock investors should be aware that Surgery Partners Inc. (SGRY) stock had its last reported insider trading activity 51 days ago on Jun 29. Evans Jason Eric, the Chief Executive Officer of the company, disposed of 1,892 shares for $45.10 on Jun 29. It resulted in a $85,329 divestment by the insider. Owens Bradley R. sold 7,191 shares at an average price of $36.31 on May 17. The insider now owns 74,189 shares following the transaction. On Mar 31, Chief Executive Officer Evans Jason Eric sold 7,674 shares at $34.26 apiece. The transaction was valued at $262,911.
Valuation Metrics
The stock’s beta is 2.75. Besides these, the trailing price-to-sales (P/S) ratio of 1.57, the price-to-book (PB) ratio of 2.03, and the price-to-cash flow ratio of 56.82 may also be considered.
Financial Health
In the three months ended June 29, Surgery Partners Inc.’s quick ratio stood at 1.60, while its current ratio was 1.80, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 1.24, and the total debt-to-equity ratio was 1.27. On the profitability front, the trailing twelve-month gross margin is 25.90% percent. In the year ended June 29, EBITDA margin amounted to 19.99%, whereas operating margins totaled 11.70%. Based on annual data, SGRY earned $574.9 million in gross profit and brought in $2.54 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 7.00%. Return on equity (ROE) for the past 12 months was -3.00%.
In Surgery Partners Inc.’s quarter-end financial report for June 29, it reported total debt of $2.5 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. SGRY’s revenue rose 7.82% to $666.2 million during the quarter, while net income inched up to $667.6 million. While analysts expected Surgery Partners Inc. to report $0.08 quarterly earnings, the actual figure was $0.28 per share. During the quarter, the company generated $124.6 million in EBITDA. The liabilities of Surgery Partners Inc. were 3.64 billion at the end of its most recent quarter ended June 29, and its total debt was $2.9 billion. The value of shareholders’ equity is $126.5 million.
Technical Picture
This quick technical analysis looks at Surgery Partners Inc.’s (SGRY) price momentum. With a historical volatility rate of 21.20%, the RSI 9-day stood at 20.79% on 18 August.
With respect to its five-day moving average, the current Surgery Partners Inc. price is down by -5.55% percent or -$1.92. At present, SGRY shares trade -18.52% below its 20-day simple moving average and +2.35% percent above its 100-day simple moving average. However, the stock is currently trading approximately -15.63% below its SMA50 and +20.08% above its SMA200.
Stochastic coefficient K was 5.56% and Stochastic coefficient D was 3.29%, while ATR was 1.19. Given the Stochastic reading of 14.46% for the 14-day period, the RSI (14) reading has been calculated as 25.07%. As of today, the MACD Oscillator reading stands at -1.52, while the 14-day reading stands at -2.62.
Analyst Ratings
BofA Securities upgraded its rating on Surgery Partners Inc. (NASDAQ: SGRY) to a Buy in a note to investors on June 02, 2023. The analysts firm previously had a Neutral rating on the stock.Surgery Partners Inc. (SGRY) has been rated Overweight by analysts. According to 0 brokerage firms, SGRY is a sell, and 2 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Surgery Partners Inc. stock as buy, with 7 recommending it as overweight.
With a median target price of $49.00, the current consensus forecast for the stock is $39.00 – $65.00. Based on these forecasts, analysts predict Surgery Partners Inc. (SGRY) will achieve an average price target of $48.90.
